Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Translational Development Acquisition (TDAC) EPS (Basic) (2024 - 2026)

Translational Development Acquisition's EPS (Basic) history spans 3 years, with the latest figure at $0.06 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 14.29% to $0.06 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.28, a 833.33% increase, with the full-year FY2025 number at $0.29, up 1550.0% from a year prior.
  • EPS (Basic) came in at $0.06 for Q1 2026, down from $0.07 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.08 in Q3 2025, with the low at -$0.02 in Q3 2024.
  • Historically, EPS (Basic) has averaged $0.04 across 3 years, with a median of $0.06 in 2025.
  • Biggest five-year swings in EPS (Basic): surged 16924.93% in 2025 and later dropped 14.29% in 2026.
  • Year by year, EPS (Basic) stood at -$0.02 in 2024, then soared by 450.0% to $0.07 in 2025, then decreased by 14.29% to $0.06 in 2026.
  • Business Quant data shows EPS (Basic) for TDAC at $0.06 in Q1 2026, $0.07 in Q4 2025, and $0.08 in Q3 2025.